Education
About Us
Working with TipRanks
Follow Us
Qlife Holding AB (SE:QLIFE)
:QLIFE
QLIFE Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr1.29 - kr5.74
Previous CloseN/A
Volume24.68K
Average Volume (3M)296.74K
Market Cap
€44.82M
Enterprise Valuekr49.94M
Total Cash (Recent Filing)€2.71M
Total Debt (Recent Filing)kr8.70M
Price to Earnings (P/E)―
Beta1.58
Next Earnings
Aug 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.73
Shares Outstanding12,484,911
10 Day Avg. Volume246,706
30 Day Avg. Volume296,743
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-80.00
Price to Sales (P/S)0.00
P/FCF Ratio-1.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
QLIFE FAQ
What was Qlife Holding AB’s price range in the past 12 months?
Qlife Holding AB lowest stock price was kr1.29 and its highest was kr5.74 in the past 12 months.
What is Qlife Holding AB’s market cap?
Qlife Holding AB’s market cap is €44.82M.
When is Qlife Holding AB’s upcoming earnings report date?
Qlife Holding AB’s upcoming earnings report date is Aug 27, 2025 which is in 43 days.
How were Qlife Holding AB’s earnings last quarter?
Currently, no data Available
Is Qlife Holding AB overvalued?
According to Wall Street analysts Qlife Holding AB’s price is currently Overvalued.
Does Qlife Holding AB pay dividends?
Qlife Holding AB does not currently pay dividends.
What is Qlife Holding AB’s EPS estimate?
Qlife Holding AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Qlife Holding AB have?
Qlife Holding AB has 12,484,911 shares outstanding.
What happened to Qlife Holding AB’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Qlife Holding AB?
Currently, no hedge funds are holding shares in SE:QLIFE
Company Description
Qlife Holding AB
Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents. The company offers Egoo.Health Platform, an integrated platform with a measuring instrument with disposable capsules and software, where each capsule contains a test for a specific biomarker or virus. Its biomarkers include C-reactive protein home-testing capsule, PHE/Phenylalanine for PKU patients, and Sars-CoV-2/Influenza multiplex for virus/bacteria tests. The company was incorporated in 2019 and is based in Helsingborg, Sweden.
Technical Analysis
SciBase Holding AB
―
Clinical Laserthermia Systems AB Class B
―
S2Medical AB Class B
―
AegirBio AB
―
Acarix AB
―